Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...
The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...
3d
About Rozebalamin (generic name: mecobalamin, development code: E0302) ...
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has ...
Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...
Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.
The Speech Accessibility Project is a research initiative to make voice recognition technology more useful for people with a range of diverse speech patterns and disabilities. The project is housed ...
A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback